Agoracom Blog Home

Posts Tagged ‘stocks’

The astronomical rise of #Esports – SPONSOR: Esports Entertainment Group $GMBL $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 5:24 PM on Friday, August 14th, 2020

SPONSOR: Esports Entertainment Group (GMBL:NASDAQ) Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is designed for the purpose of facilitating as much of this wagering as possible.  LEARN MORE.

The astronomical rise of esports

  • If this is your first time hearing about esports, you’re behind the curve — esports is one of the fastest growing industries in the world
  • Last year, the esports industry had an estimated audience of 453 million, up from 293 million in 2016

By Derek Chen July 22, 2020

If you’re bored during quarantine and looking for a fun, popular and lucrative way to pass the time, consider putting down that baking pan or pausing that Netflix show and picking up a controller to join the world of esports, a hot trend in the media and entertainment industry. Esports is a competitive video game sport that has grown to incorporate organized tournaments with professional players. Before the COVID-19 pandemic, these tournaments were almost always in-person events, complete with live audiences and referees who monitored potential cheating. 

If this is your first time hearing about esports, you’re behind the curve — esports is one of the fastest growing industries in the world. Last year, the esports industry had an estimated audience of 453 million, up from 293 million in 2016. By 2021, that number is expected to reach 557 million. And it’s not just your stereotypical G Fuel-drinking, Doritos-loving high school guys pushing this growth: Universities across the nation have begun investing in this industry. According to the National Association of Collegiate Esports, more than 170 U.S. colleges have varsity esports programs and are offering around $16 million per year in scholarships. College esports tournaments have attracted over 1,350 schools and 40,000 players.

Even the most traditional Wall Street bankers are taking notice of this industry’s potential to make big money. Most esport viewers are in their teens or early twenties, a much-coveted demographic for advertisers, and 43% of esports fans have an annual household income of $75,000. For brands who want to acquire new, young, high-spending customers, esports is especially attractive. Louis Vuitton, for example, is collaborating with video game developer Riot Games to design virtual items in League of Legends (such as “prestige skins”) that players can buy using real money. The fashion brand also spent 900 hours creating an extravagant custom trophy case that combines Louis Vuitton’s bougie flair with League of Legends’ medieval style. Meanwhile, some companies have profited from esports without even trying. In 2018, professional gamer Ninja crashed the website of MeUndies just by mentioning the underwear brand on a livestream. 

Why has esports experienced this meteoric rise in popularity and significance? From a social standpoint, esports is far more inclusive than other sports. Men and women of nearly all ages and from various social groups and demographics can play on the same teams and easy translation in the virtual format tears down the language barrier. Unlike in real sports, where genetics may greatly affect your potential to succeed, in esports, anyone with enough practice can become a competent gamer — and everyone has the potential to compete with the best.

From a technological standpoint, video games with increasingly life-like visuals have enhanced the viewing experience. Games now frequently run on a smooth 60 frames per second with 4K resolution, resulting in extremely realistic animations and an immersive experience. The rise of esports can also be traced to the rise of video games among youth. According to Pew Research, 90% of teens aged 13-17 played video games in 2018. The percentage is 97% among boys of that age. With a high number of youth playing games, it’s not hard to imagine that a few would get interested in esports and start the trend among their peers. 

The viewership of esports will only grow, especially as famous names in other industries, such as Jennifer Lopez and Travis Scott, associate themselves with leading esports tournaments. The growth of advertising in esports means that brands will now interface directly with previously hard-to-reach audiences, generating previously unthinkable ways to advertise and making space for unlimited creative potential. So, if you want to curb your bread-making addiction during quarantine and spend this extra time getting ahead of the game (pun absolutely intended), consider esports.

Source: https://www.dukechronicle.com/article/2020/07/the-astronomical-rise-of-esports

VIDEO: Red Light Holland $TRIP.ca #Psychedelics Will Be Hitting The Shelves Soon, Followed By Production of 100,000 Grams Of Magic Truffles

Posted by AGORACOM-JC at 4:02 PM on Thursday, August 13th, 2020
Red-Light-Holland-Square

The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.  

Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:

TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor.  Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.

BUSINESS – The Company’s recreational brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops by mid-September, as well as, its e-commerce platform through microdose packs.   To this end, TRIP has already  commenced growing its first crop of magic truffles months ahead of schedule.  The initial batch of approximately 100,000 grams of magic truffles available in late October, 2020.

As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it.  The AGORACOM thesis of small cap wealth this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!

If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Future #Chelsea stars use augmented reality #AR app to supplement training SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 3:25 PM on Thursday, August 13th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Future Chelsea stars use augmented reality app to supplement training

Chelsea’s stars of tomorrow are already honing their skills by using the Blues’ groundbreaking new augmented reality mobile phone app.

The Stamford Bridge club’s junior academy players are using the Perfect Play app to supplement their training.

Academy graduate Reece James has provided the first digital masterclass for the tool that is now available for anyone to download.

24 hours have passed since the official launch of Perfect Play and we’re so overwhelmed by the support and amazing comments! There’s so much more to come from Perfect Play! Download today and #TrainWithTheBest

Download here: https://t.co/nEEQ3LY40V pic.twitter.com/P0yT5jIegv

— Perfect Play (@PerfectPlay) August 13, 2020

The new app uses video tracking technology to map the user’s space and return inch-perfect data on performance and ability in a host of individual or team challenges.

Chelsea’s academy staff and developers have worked since December 2018 on a product launched this week, one which they believe can take youth training to a whole new digital level.

Chelsea Under-11s head coach Sam Page has helped stars like Mason Mount and Tammy Abraham through the Stamford Bridge ranks and has taken a lead role on the new app.

“We’ve actually already used the app with our academy players and it’s been a really interesting part of our home learning programmes that we developed during the course of the pandemic lockdown,” Page told the PA news agency.

“It presented a really exciting opportunity for us with Perfect Play, and we offered the testing version of the app to our academy players from the Under-Nines to Under-13s as part of their home learning programme.

“They tested it for us and had it as part of their programme, so we had some really nice feedback and were able to make some refinements off the back of that.

“And moving forward we’re really keen for it to be a supplementary part of the programme for the youngest age groups that we only see on a part-time basis.

“Our goal is to remain at the forefront of what’s happening in global academy football, we always aspire to be world-leading.

It’s been fantastic working on this project for the past 18months. I am now really excited to see where we go next. https://t.co/o0h7pswPpy

— Sam Page (@sampage1871) August 12, 2020

“Our head of youth development Neil Bath really drives us as coaches to think in a fully-integrated fashion, and about all the technologies that come with that.

“Perfect Play is a really good example of how as coaches we can think about what technology can do to enhance our coaching practice.”

Manager Frank Lampard awarded a record number of senior debuts to home-grown stars in his first season at the Stamford Bridge helm.

Page admitted his own pride at seeing such a bumper crop of academy graduates, especially when witnessing England midfielder Mount hit the net in the 1-1 home draw with Leicester at the start of the campaign.

“There is immense pride in seeing a lot of our lads playing at Stamford Bridge,” said Page.

“For me the memory of Mason scoring against Leicester in the first game, I’ve been to many games at Stamford Bridge but that’s a very special memory for me.

“We talk to our players about it now, about the pathway and the expectations that Frank has, and the things he talks to us as academy staff about; the commitment, hard work, dedication, all of those core fundamental skills that we’ve also tried to embed in the Perfect Play app.” Stars like Mason Mount, pictured, were helped through Chelsea’s academy by Sam Page, one of the key contributors to the club’s new training app (Alastair Grant/NMC Pool)

Product owner Steve Didd will continue to work with Chelsea on refining an app he believes can help radically alter general sports training.

“Technology is going to be hugely influential in terms of how people train, and it’s something we’re hugely excited about delivering within Perfect Play,” Didd told the PA news agency.

“Our goal with the product is to make kids better footballers, and this technology enables us to show them they are getting better, because it captures their performances.

“Kids are very tech savvy now, but this should be extremely intuitive to set up and use and we believe it’s going to become an essential part of football training moving forwards.

“We’re taking elite academy methodologies that have been developed over decades, digitising that, and allowing kids to have that same kind of training, that wouldn’t be accessible elsewhere. So it’s there to help kids improve and gain the edge.

“We already have a masterclass in the app with Reece James.

“We’re heavily involved with the first-team men and women as well as the academy kids who feature. And we’ll be doing more masterclasses with players from both the men’s and women’s team.”

Source: https://www.shropshirestar.com/sport/uk-sports/2020/08/13/future-chelsea-stars-use-augmented-reality-app-to-supplement-training/

Datametrex $DM.ca Secures $2.3M Contract

Posted by AGORACOM-JC at 10:07 AM on Thursday, August 13th, 2020
  • Entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd., bringing the total gross sales to $3.3M this year so far
  • LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam
  • Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor
  • LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions.

TORONTO, Aug. 13, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd. (“LOTTE”), bringing the total gross sales to $3.3M this year so far.

LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam.

Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor. Datametrex has demonstrated to be a quality, reliable, and trustworthy partner, with an opportunity to grow within the 934 companies in the LOTTE family.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data in order to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.

Datametrex plans to deliver the contract in August with full payment in September 2020.

Datametrex is also pleased to share that the Company has won a tender from LOTTE Property and Development Co. Ltd. for approximately $100K.

About LOTTE Group

LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Else Nutrition $BABY.ca to Present at August 2020 Lytham Partners Virtual Investor Growth Conference $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:14 AM on Thursday, August 13th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

VANCOUVER, BC August 13, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, August 19, 2020 at 10:00am ET (7:00am PT).

A webcast of the presentation will be posted under the investor relations section of Else’s website at elsenutrition.com/pages/investor-relations. The presentation can also be accessed at https://www.webcaster4.com/Webcast/Page/2472/36486 or www.lythampartners.com/virtual. A replay of the presentation will be available following the event.

Management will also be participating in virtual one-on-one meetings on August 19-20, 2020. To arrange a meeting, please contact Ben Shamsian of Lytham Partners at [email protected] or visit www.lythampartners.com/virtual.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings Inc.

ImagineAR $IP.ca $IPNFF and The Pittsburgh Gateways Corporation Sign MOU To Integrate Augmented Reality Into the Energy Innovation Center $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:04 AM on Thursday, August 13th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced the signing of an MOU with the Pittsburgh Gateways Corporation, a developer of technology-based research centers in the United States
  • Since its inception, Gateways has established, or formed collaborative alliances with, over 30 technology centers, primarily in Western Pennsylvania, but extending throughout the Northeastern and Midwestern United States
  • The organization has also assisted in the formation of over 60 new or development-stage ventures, many of which are thriving today as successful business and economic development enterprises. Its efforts have contributed to the creation of thousands of jobs.

VANCOUVER, BC and ERIE Pa., Aug. 13, 2020  ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, is pleased to announce the signing of an MOU with the Pittsburgh Gateways Corporation  (“Gateways”), a developer of technology-based research centers in the United States.

Since its inception, Gateways has established, or formed collaborative alliances with, over 30 technology centers, primarily in Western Pennsylvania, but extending throughout the Northeastern and Midwestern United States.  The organization has also assisted in the formation of over 60 new or development-stage ventures, many of which are thriving today as successful business and economic development enterprises. Its efforts have contributed to the creation of thousands of jobs.

Pittsburgh Gateways Corporation CEO Robert Meeder stated: “As an economic development organization, we focus on integrating advanced immersive technology such as augmented reality into our center as well as introducing it to our tenants.  ImagineAR is a leader in the mobile augmented reality in the North America and we are truly excited to partner with them and drive new AR engagements and revenue together.  The applications of ImagineAR into our Energy Innovation Center will be extensive.”

Gus Frerotte, 15 year NFL Pro Bowl QB and Developer/Coordinator of Media and Communications Operations at the EIC, added “From the first moment I set foot in the EIC I knew I wanted to be part of this team. I admire the leadership of Pittsburgh Gateways Corporation and their mission for the EIC. The EIC is a robust intersection of research, training and community service and my goal is to help with the application of my skills and experience in communications and the development of human performance tools. When I first spoke with Neal Bendesky, VP Sports & Events of ImagineAR Inc., I knew that the EIC would benefit from this collaboration.  I am excited for the future as the EIC and its partners come to life.”

ImagineAR CEO Paul Silverrstieen added: “We are honored to be selected as the Augmented Reality Platform Solution for the prestigious Gateways organization. Their reputation as a leader in the energy sector as well as high-tech incubators, provides ImagineAR the opportunity to work with energy and entrepreneurial companies to create AR engagements and activations together. This partnership is expected to develop a new sector revenue channel for ImagineAR. “

About Pittsburgh Gateways Corporation

Pittsburgh Gateways Corporation’s mission is to provide strategic planning, development and direct management assistance for communities, community-based economic development organizations, research & academic institutions, and private entities seeking the acceleration of technology-based businesses. Incorporated into this mission is our goal to combat community deterioration in the City of Pittsburgh and other economically distressed areas of Pennsylvania. Pittsburgh Gateways Corporation is registered as a 501(c)(3) non-profit organization. The website is https://www.pghgateways.org/.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons,3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

For more information or to explore working with Imagination Park, please email [email protected], or visit www.imagineAR.com.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR’s management. Although Imagine AR Inc. believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Imagine AR Inc. can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR Inc.  disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.  

SOURCE ImagineAR 

MedX Health $MDX.ca continues its global expansion in the fight against skin cancer $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 5:53 PM on Wednesday, August 12th, 2020
Home - MedX Health

Matthew Bohlsen |

Skin cancer is the most common cancer in the United States and worldwide, but early screening can save lives. Did you know these gruesome facts?

  • One in every three cancers diagnosed is skin cancer.
  • Between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year.
  • 1 in 5 Americans will develop skin cancer by the age of 70.
  • More than 2 people die of skin cancer in the U.S. every hour.

Clearly the world needs a much better early skin cancer screening technology.

MedX Health Corp. (TSXV: MDX) is a leading medical device and software company focused on the early detection of skin cancer. MedX has approvals in 35 countries and distribution agreements in place for its key skin cancer diagnostic products – SIAscope and DermSecure™ telemedicine platform.

Following on from MedX’s regulatory approval and distribution agreement in Brazil (read here), the Company recently announced an exciting exclusive distribution agreement to launch SIAscopy on DermSecure™ in Mexico with EMC LABS, S.A.P.I. DE C.V.operating as MedX Mexico. MedX Mexico plans to launch an aggressive ease-of-access skin scanning/assessment program throughout Mexico, using MedX’s SIAscopy on DermSecure™ Telemedicine platform. MedX Mexico will cover all the upfront costs for application for regulatory approval in Mexico, all marketing costs, and will utilize their large-scale distribution network in Mexico.

MedX Mexico’s, President and CEO, Carlos Vizcaino, states:

“There is a significant opportunity for MedX’s rapid skin assessment technology in Mexico, as skin cancer is a very common type of cancer in Mexico……MedX’s SIAscopy on DermSecure™ Telemedicine platform and advanced SIAscopy imaging technology is a perfect solution to assist dermatologists and physicians in the diagnosis process for early detection of melanoma.”

Masterplan

MedX Health’s masterplan is to continue to rollout distribution agreements with partners globally. So far Brazil and now Mexico are underway. MedX’s revolutionary skin cancer detection device is approved in the USA, Canada, Brazil, Australia, New Zealand, the European Union, Turkey, and many other places. In total MedX’s device has achieved regulatory approval in 35 countries. This means we can expect further distribution agreements in the future to many of the above countries. The potential for future revenues is enormous.

MedX’s business model is similar to Software as a Service (SaaS) companies. The revenue model uses front-end hardware sales coupled with recurring “platform” revenue based on a minimum number of screens per device (360/year at $10/image).

2019 revenues were only small at C$860,248, and 1st quarter 2020 C$95,544, as the Company was impacted by COVID-19 and had yet to ramp up distribution as is now occurring in 2020. For a guide on where revenues are headed the next two years the Beacon Securities report is most useful.

The report’s analysts says MedX has strong visibility on initial orders from the MedX Brazilian distribution partner, that could result in $8 million of hardware sales over the next 2 years and a run-rate of $14 million of high margin, recurring platform revenue by the end of FY21. Given that MedX currently trades on a market cap of C$24 million, the C$14 million, if achieved, would mean MedX would trade on a 2022 market cap/sales ratio of only 1.7. Beacon Securities rates MedX Health a ‘buy’ with a Price Target of C$0.45. Given the stock currently trades at C$0.135, the C$0.45 price target represents a very significant upside of 233% or a 3.3 fold gain.

Closing remarks

It is very clear to me that the market is yet to wake up to the potential very large boost in revenues that MedX is working to achieve, now with distribution agreements in both Brazil and Mexico.

Detecting skin cancer is an enormous global need and MedX is working hard to fill this need. MedX has the right device and approvals in 35 countries. All that is needed now is further distribution agreements and revenue to flow. The opportunity for investors to get in early on such a great company with a very bright future still exists. I would not recommend waiting too long as the cheap valuation is unlikely to last long, especially as further new deals are announced.

Source: https://investorintel.com/sectors/biotech-healthcare/biotech-intel/medx-health-continues-global-expansion-fight-skin-cancer/

Innocan $INNO.ca Engages Endless Sky to Manufacture and Distribute Innocan’s CBD Cosmetic Products in Canada $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:09 PM on Tuesday, August 11th, 2020
Innocan-Blog
  • Entered into a manufacturing and distribution agreement with Endless Sky Incorporated, a Canadian large scale Cannabis extractor based in Calgary, Alberta
  • Under the Agreement, ESI will serve as the exclusive distributor of Innocan’s CBD products in Canada under a license granted by Innocan. ESI will manufacture Innocan’s CBD products at ESI’s Health Canada licensed facility in Redvers, Saskatchewan.
  • ESI’s manufacturing and distribution rights consist of the Relief and Go CBD Spray and Cream and the SHIR Eye Serum, Face Cream and Night Cream.

Herzliya, Israel and Calgary, Alberta – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its wholly owned subsidiary, Innocan Pharma Ltd. (“Innocan Israel”) has entered into a manufacturing and distribution agreement (the “Agreement”) with Endless Sky Incorporated (“ESI”), a Canadian large scale Cannabis extractor based in Calgary, Alberta.

Under the Agreement, ESI will serve as the exclusive distributor of Innocan’s CBD products in Canada under a license granted by Innocan. ESI will manufacture Innocan’s CBD products at ESI’s Health Canada licensed facility in Redvers, Saskatchewan. ESI’s manufacturing and distribution rights consist of the Relief and Go CBD Spray and Cream and the SHIR Eye Serum, Face Cream and Night Cream. The Agreement conditional upon ESI receiving Health Canada’s approval no later than December 31, 2020. According to the agreement, ESI shall pay Innocan Israel a cash license fee per Product as well as royalties based on net sales of the Products by ESI.

The Agreement is for a term of 12 months and will be automatically extended for additional periods of 12 months each based on ESI achieving minimum sales targets for the previous 12 months period.

ESI is responsible for meeting all Canadian regulations and registrations.

“Endless Sky is thrilled to exclusively manufacture and distribute Innocan’s SHIR Beauty & Science skin care line as well their Relief & Go topical products in Canada, with the future potential to access additional countries where cannabis regulations permit, and terms agreed by the parties. We believe that Innocan’s patent-pending, CBD-integrated products will be some of the highest quality CBD products to enter the market to date. Israel is well known as the global leader in CBD research and Innocan is leveraging that knowledge with a team of proven experts in the cosmetics, healthcare, sports medicine, and wellness markets. Innocan’s diligent commitment to research and development and its visionary thinking has positioned both companies to be market leaders in the CBD consumer packaged goods products space. The pharmaceutical expertise of Innocan together with Endless Sky’s large extraction capacity and manufacturing capabilities will combine to bring top of the line products to market at scale and price points that will allow for wide market access. This Agreement also positions both companies for CBD deregulation, allowing Endless Sky and Innocan’s CBD products to be further scaled through national retailers at such time. We are very excited to bring these products into the Canadian market in the very near future,” says CEO of Endless Sky, Travis George.

Iris Bincovich, Innocan’s Founder and CEO, commented: “We are thrilled to have found the right party to distribute and manufacture our CBD line of products in Canada. Distributing our CBD line of products is a significant milestone for us, given the importance of Canada to the world of CBD. Collaboration with Endless Sky, one of Canada’s largest extracting companies, will allow us to enter Innocan’s revolutionary wellness brands into the Canadian market”.

About Endless Sky Incorporated:

Endless Sky Incorporated is a Canadian large scale cannabis C02 extractor focusing on Cannabinoids. Endless Sky has a Health Canada standard processing licence which allows production of consumer packaged goods with Cannabinoids as an additive.

With top of market throughput, hemp genetics breeding program, strict QA/QC standards, and EU GMP design, Endless Sky is poised to be a global leader in low cost premium active pharmaceutical ingredients for the health, wellness and beauty markets.

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of InnoCan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, the effectiveness and safety of the Company’s products, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by InnoCan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact InnoCan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Iconic $ICM.ca Initiates Drilling Program at Bonnie Claire Lithium Project, Nevada $LI.ca $MGG.ca $PAC.ca $CYP.ca $NEV.ca

Posted by AGORACOM-JC at 9:12 AM on Tuesday, August 11th, 2020
  • Announced that it has mobilized a drill crew and drilling equipment to the Bonnie Claire Lithium Deposit in Nevada
  • Exploration program will consist of 3-5 vertical reverse circulation (RC) holes 90-120 meters (300-400 feet) in depth and 2 vertical core holes 90-120 meters (300-400 feet) in depth

Vancouver, British Columbia–(August 11, 2020) – Iconic Minerals Ltd. (TSXV: ICM) (OTC Pink: BVTEF) (FSE: YQGB) (“Company” or “Iconic”) is pleased to announce that it has mobilized a drill crew and drilling equipment to the Bonnie Claire Lithium Deposit in Nevada. The drilling contract was signed with Harris Exploration Drilling of Fallon, Nevada, for both core and RC drilling.

The exploration program will consist of 3-5 vertical reverse circulation (RC) holes 90-120 meters (300-400 feet) in depth and 2 vertical core holes 90-120 meters (300-400 feet) in depth (the “Drill Holes”). The RC drilling will provide additional samples for metallurgical testing as well as expand the existing resource. The core holes will be the first drilled on the Bonnie Claire Project, and will be used in engineering studies for a Preliminary Economic Assessment (PEA).

All of the planned Drill Holes are south of Iconic’s previous deep drilling (BC1601-1801) in an area of linear lithium anomalies found by surface grid sampling. It is hoped that the sediment hosted lithium will begin very shallow in this area which may allow for future bulk sampling using an excavator. In past drilling the shallowest depth of lithium rich sediments that was intercepted was at 6 meters (20 feet) and contained +600 ppm Li, which increased at depth with Li values up to 2250ppm. In addition to collecting the sediments for testing, because the surface anomalies may indicate near-surface lithium brine, preliminary semi-quantitative brine samples will also be taken from all holes during drilling.

The Bonnie Claire Lithium Property Characteristics:

The Property is located within Sarcobatus Valley that is approximately 30 km (19 miles) long and 20 km (12 miles) wide. Quartz-rich volcanic tuffs, that contain anomalous amounts of lithium, occur within and adjacent to the valley. Geochemical analysis of the local salt flats has yielded lithium values up to 340 ppm. The gravity low within the valley is 20 km (12 miles) long, and the current estimates of depth to basement rocks range from 600 to 1,200 meters (2,000 to 4,000 feet). The current claim block covers an area of 35 km2 (13.5 mi2) with potential to be underlain by lithium-rich sediments.

On behalf of the Board of Directors

SIGNED: “Richard Kern

Richard Kern, President and CEO
Contact: Keturah Nathe, VP Corporate Development (604) 336-8614

For further information on ICM, please visit our website at www.iconicminerals.com
The Company’s public documents may be accessed at www.sedar.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Avicanna $AVCN.ca and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived #CBD-Based Topical Products in the United States $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 8:06 AM on Tuesday, August 11th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Entered into a distribution agreement for the exclusive distribution of Avicanna’s advanced and clinically backed CBD-based cosmetic and topical products Pura H&W™ by RWB in the US and certain other markets.
  • The partnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line

TORONTO, Aug. 11, 2020 – Avicanna Inc. (“Avicanna”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of organic and sustainable plant-derived cannabinoid-based products, and Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) (“RWB” or “Red White & Bloom”) are pleased to announce that they have entered into a distribution agreement for the exclusive distribution of Avicanna’s advanced and clinically backed CBD-based cosmetic and topical products Pura H&W™ by RWB in the US and certain other markets.

The $532 billion beauty industry continues growing rapidly and new trends such as the introduction of CBD cosmetics is anticipated to establish a strong market presence in markets that permit retail sales such as the United States. The Pura H&W branded products utilize hemp-derived CBD, the non-psychoactive and non-controlled cannabinoid, which allows for cosmetic designation and retail sales.

The launch of this innovative and premium hemp-derived CBD product line will leverage from the growing use of online platforms for shopping including Pura H&W’s own e-commerce platform, third party e-commerce channels, and “big box” retailers in addition to the existing commercial infrastructure of RWB in the United States.

Brad Rogers, chairman and chief executive officer of RWB, stated: “Throughout my career, I have seen tremendous success licensing brands, strategically leveraging them for the demographics that recognize the best in class quality & efficacy, and then listing them in big box and specialty retailers. This agreement paves a path that will allow RWB and Avicanna to grow together well into the future beyond our news today.”

Under the agreement, which has an initial five-year term, RWB will exclusively distribute the Pura H&W™ brand and certain other white label brands at RWB’s direction. Having been developed by researchers and collaborators from world class medical and academic institutions, the Pura H&W™ line of products has been developed through a scientific and evidence-based approach. This approach in product development has allowed Avicanna to synergistically combine natural ingredients with hemp-derived CBD in advanced and proprietary formulations that have completed 3 cosmetic human clinical studies. Product development is always commenced with the consumer in mind and specific needs are addressed through analysis in observational as well as interventional clinical studies. Avicanna’s hemp-derived CBD infused cosmetics and topicals equip RWB with the opportunity to set the standards with advanced research and development for hemp-derived CBD cosmetics and GMP manufacturing.

The 3 cosmetic clinical studies were completed on Avicanna’s formulations targeted at cosmetic factors associated with aging, acne-prone skin, and eczema-prone skin. The successfully completed studies involved 156 patients that were tested for both safety and certain derma-cosmetic endpoints, including hydration and excess oil production. The results of all three studies achieved positive results in the endpoints with no adverse effects, making products part of one of the only cannabinoid consumer product lines with human safety and efficacy data.

Aras Azadian, CEO of Avicanna, commented: “After years of R&D and clinical development of what we believe is the most advanced line of CBD skin care products, we are thrilled to have partnered up with the team at RWB, who provide an ideal partner for Avicanna and the Pura H&W line of products. We believe their access and expertise in the US market through commercial and retail channels will allow the Pura H&W branded products to reach their potential as the leading skin care brand.”

Terms of the agreement

RWB will pay Avicanna an upfront licensing fee in the amount of two hundred fifty thousand Canadian dollars (CAD$250,000) in cash, along with minimum purchase requirements for the rights to be the exclusive distributor of Avicanna’s Pura H&W branded cosmetic products in the US. Under the agreement, RWB also has the right to purchase Avicanna’s cosmetic products for distribution into the US and certain other territories under brands of RWB’s choosing. The initial product offerings under the agreement will include body and face lotions, cosmetic creams, gels and serums, as well as soaps and bath bombs.

To the knowledge of the Company, it carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.

About Red White & Bloom Brands Inc.

The Company is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominately focusing its investments on the major US markets, including Michigan, Illinois, Massachusetts, California, and Florida with respect to cannabis, and the US and internationally for hemp-based CBD products.

For more information about Red White & Bloom Brands Inc., please contact:

Tyler Troup, Managing Director

Circadian Group IR

[email protected]

Visit us on the web: www.RedWhiteBloom.com

Follow us on social media:

Twitter: @rwbbrands

Facebook: @redwhitebloombrands

Instagram: @redwhitebloombrands

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of Avicanna or RWB to perform under the agreement, the manufacturing of the products, the shipping and delivery of the products to customers in the United States and worldwide, and the appropriate education and marketing efforts. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, the delay or failure to receive regulatory approvals, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.